| id,sequence_length,predicted_confidence,disorder_fraction,binding_site_uncertainty,experimental_support,model_disagreement,proposed_use,gold_uncertainty_flag,gold_uncertainty_type,gold_recommendation | |
| PSU-T01,155,0.59,0.44,high,no_experimental_data,medium,drug_design,yes,disorder_high,Validate disorder and avoid rigid docking | |
| PSU-T02,480,0.91,0.05,low,cryo_em_support,low,drug_design,no,low_uncertainty,Proceed with structure guided design | |
| PSU-T03,210,0.72,0.18,medium,no_experimental_data,high,mutation_mapping,yes,model_disagreement,Compare models and validate key regions | |
| PSU-T04,120,0.49,0.51,high,no_experimental_data,high,function_annotation,yes,confidence_low,Avoid structural inference. Use sequence level analysis | |
| PSU-T05,360,0.83,0.10,low,xray_support,low,docking,no,moderate_confidence,Proceed with docking but monitor flexible regions | |
| PSU-T06,298,0.65,0.29,medium,no_experimental_data,medium,drug_design,yes,confidence_borderline,Seek experimental validation before design | |
| PSU-T07,520,0.94,0.03,low,cryo_em_support,low,mutation_mapping,no,low_uncertainty,Proceed with mapping | |
| PSU-T08,190,0.57,0.35,high,no_experimental_data,high,binding_analysis,yes,disorder_high,Do not trust binding site geometry yet | |
| PSU-T09,410,0.78,0.11,medium,xray_support,medium,drug_design,no,moderate_confidence,Proceed with caution and cross check models | |
| PSU-T10,240,0.62,0.26,medium,no_experimental_data,high,function_annotation,yes,model_disagreement,Use consensus modeling and experimental follow up | |